Tuberculous meningitis: Difference between revisions

From IDWiki
m (Aidan moved page Mycobacterium tuberculosis Tuberculous meningitis to Tuberculous meningitis without leaving a redirect)
mNo edit summary
Line 1: Line 1:
 
= Definition =
= Tuberculous meningitis =
 
 
== Definition ==
 
   
 
* Meningeal infection by ''Mycobacterium tuberculosis''
 
* Meningeal infection by ''Mycobacterium tuberculosis''
   
== Classification ==
+
= Classification =
   
 
* Stage 1: normal level of consciousness, no focal neurological deficits
 
* Stage 1: normal level of consciousness, no focal neurological deficits
Line 11: Line 9:
 
* Stage 3: seizures, comatose
 
* Stage 3: seizures, comatose
   
== Epidemiology ==
+
= Epidemiology =
   
 
* About 1% of TB cases in Canada
 
* About 1% of TB cases in Canada
   
== Differential Diagnosis ==
+
= Differential Diagnosis =
   
 
* Fungal meningitis
 
* Fungal meningitis
Line 21: Line 19:
 
* Neoplasm
 
* Neoplasm
   
== Risk Factors ==
+
= Risk Factors =
   
 
* Young
 
* Young
Line 28: Line 26:
 
* Previous TB
 
* Previous TB
   
== Presentation ==
+
= Presentation =
   
=== History ===
+
== History ==
   
 
* Prodrome (1-3 weeks)
 
* Prodrome (1-3 weeks)
Line 46: Line 44:
 
* Seizures
 
* Seizures
   
=== Physical Exam ===
+
== Physical Exam ==
   
 
* Meningeal symptoms
 
* Meningeal symptoms
Line 58: Line 56:
 
* Confusion, coma
 
* Confusion, coma
   
== Investigations ==
+
= Investigations =
   
 
* Lumbar puncture
 
* Lumbar puncture
Line 66: Line 64:
 
* CT head
 
* CT head
   
== Management ==
+
= Management =
   
 
* Rule out neoplasm and fungus, then start empiric treatment
 
* Rule out neoplasm and fungus, then start empiric treatment
Line 75: Line 73:
 
** High risk of IRIS
 
** High risk of IRIS
   
== Prognosis ==
+
= Prognosis =
   
 
* Depends on stage at presentation
 
* Depends on stage at presentation
Line 90: Line 88:
 
** Ophthalmoplegia
 
** Ophthalmoplegia
 
** Hemiparesis
 
** Hemiparesis
  +
  +
[[Category:Tuberculosis]]

Revision as of 07:47, 13 August 2019

Definition

  • Meningeal infection by Mycobacterium tuberculosis

Classification

  • Stage 1: normal level of consciousness, no focal neurological deficits
  • Stage 2: decreased level of counsciousness, significant focal neurological deficits
  • Stage 3: seizures, comatose

Epidemiology

  • About 1% of TB cases in Canada

Differential Diagnosis

  • Fungal meningitis
  • Sarcoidosis
  • Neoplasm

Risk Factors

  • Young
  • Female
  • Originally from endemic country
  • Previous TB

Presentation

History

  • Prodrome (1-3 weeks)
    • Personality changes
    • Low-grade fever
    • Malaise
    • Weight loss
    • Gradual onset of worsening headache
  • Headache
  • Fevers
  • Vomiting
  • Confusion
  • Personality changes
  • Photophobia (only 5-10%)
  • Seizures

Physical Exam

  • Meningeal symptoms
  • Fevers
  • Vomiting
  • Meningismus
  • Focal neurological deficits
    • Cranial nerve palsies in VI, III, and IV
    • Hemiplegia, paraplegia
    • Urinary retention
  • Confusion, coma

Investigations

  • Lumbar puncture
    • Increased lymphocytes, decreased glucose, and increased protein
    • Need 3-5mL of CSF for culture
    • May need serial LPs
  • CT head

Management

  • Rule out neoplasm and fungus, then start empiric treatment
  • HIV test (delay antiretrovirals by 8 weeks, though)
  • Standard HREZ x2mo then HR x7-10mo
    • Can replace ethambutol with a fluoroquinolone
  • Dexamethasone 3mg po qid x2wk then taper over 6-8wks
    • High risk of IRIS

Prognosis

  • Depends on stage at presentation
  • Mortality is high
    • Stage 1: 10-20%
    • Stage 2: 20-40%
    • Stage 3: 60%
  • Morbidity is high, with about 20% of patient being left with significant neurological sequelae
    • Mental retardation
    • Psychiatric disorders
    • Seizures
    • Blindness
    • Deafness
    • Ophthalmoplegia
    • Hemiparesis

References

  1. ^  GE Thwaites, TTH Chau, K Stepniewska, NH Phu, LV Chuong, DX Sinh, NJ White, CM Parry, JJ Farrar. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. The Lancet. 2002;360(9342):1287-1292. doi:10.1016/s0140-6736(02)11318-3.